Epigenetic drug-sensitive biomarkers for cancer

Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.

GE Healthcare wins FDA clearance for Alzheimer’s imaging software

Dive Brief: GE Healthcare has received 510(k) clearance for a tool designed to help clinicians assess people who may have Alzheimer’s disease, the company said

September 20, 2024

Hospitals See Strong Financial Performance in April, Despite Rising Expenses

What You Should Know: – U.S. hospitals and health systems continued to experience positive financial performance in April, with patient demand and revenues rising for

June 3, 2024

Unlearn Raises $50M to Accelerate AI-Powered Clinical Trials with Digital Twins

What You Should Know: – Unlearn®, a leading AI company using digital twins to revolutionize clinical trials, announced today a $50M Series C funding round

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.